The genetics of pancreatic cancer

When Alex Trebek was diagnosed with pancreatic cancer earlier this year, it put a spotlight on a condition that hasn’t received enough coverage: pancreatic cancer. With 56,000 adults diagnosed in the US every year, pancreatic cancer has quietly become the fourth leading cause of cancer death in men and women in the US. While most…

Read More

Hereditary cancer test menu update

At Invitae, we are committed to continually refining our services with the goal of offering the most comprehensive and medically-actionable genetic tests for our patients. To that end we’re excited to announce an update to our hereditary cancer testing menu. Genes added to our primary panels are genes that have a strong association with cancer…

Read More

Now a UnitedHealthcare Preferred Lab Network Provider

Invitae is pleased to announce that we’ve been named a Preferred Lab Network Provider with UnitedHealthcare. This designation is a reflection of our ongoing commitment to making high-quality genetic testing both affordable and accessible. From UnitedHealthcare: UnitedHealthcare is working to make it easier to identify and choose lab providers who have committed to the Triple…

Read More

How much do you know about genetic testing?

It’s National DNA Day, a day when students, teachers, and the public can learn more about genetics and genomics. The day commemorates the discovery of DNA’s double helix in 1953 and the completion of the Human Genome Project in 2003. To celebrate DNA Day and spread awareness of how our genes and genetic testing can…

Read More

Genetics Insider: March 2019

Literature review  New guidelines for breast surgeonsThe American Society of Breast Surgeons (ASBrS) has expanded its genetic testing guidelines. The new recommendations include: • Genetic testing should be made available to all patients with breast cancer. • Patients who had genetic testing previously may benefit from updated testing. Tools for Pitt-Hopkins syndromeThe first consensus statement for…

Read More

Genetics Insider: January 2019

Literature review   Invitae news   Diagnosing difficult diseasesThe Undiagnosed Disease Network (UDN) studied changes in medical management for previously undiagnosed patients who subsequently received a genetic diagnosis. • The UDN applied a multidisciplinary model for evaluation of 601 patients referred to the program. • Establishing a diagnosis led to 21% of patients receiving changes to their…

Read More

Genetics Insider: Inaugural edition

Welcome to the inaugural edition of Genetics Insider! As your partner in genetic testing, we’re working to gather the most up-to-date resources for you. Every other month, we’ll bring you updates from the community, as well as inside Invitae. We hope you enjoy and, as always, invite your feedback. Thanks for partnering with Invitae! You’ve…

Read More

Lower patient-pay price: $250

We’ve lowered our patient-pay panel price from $475 to $250. Invitae’s mission is to make high-quality genetic testing affordable and accessible to everyone who needs it. Today we’ve taken another step forward on behalf of patients. To help patients who do not meet coverage policies for testing, have high-deductible plans, or aren’t covered by insurance,…

Read More

Ask the expert: Common questions about cystic fibrosis

We’ve teamed up with one of our in-house experts to talk about the importance of screening for cystic fibrosis. In the short video below, you’ll hear from Dana Neitzel, one of Invitae’s licensed genetic counselors (who was formerly at Good Start Genetics). Dana has a wealth of knowledge when it comes to cystic fibrosis and…

Read More